Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cooper

Showing results (831-840 of 855) with videos related to

Pageof 86
Sort By:
Military Medicine|April 6, 2016
Economic Burden of Hearing Loss for the U.S. Military: A Proposed Framework for EstimationHasanat Alamgir, David L Tucker, Sun-Young Kim, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Military Medicine|December 4, 2014
The Department of Defense Epidemiologic and Economic Burden of Hearing Loss studySharon P Cooper, Hasanat Alamgir, Kristina W Whitworth, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996T B Shows, M Alders, S Bennett, et al.
Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonistsDonald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Novel Orthopoxvirus Infection in an Alaska ResidentYuri P Springer, Christopher H Hsu, Zachary R Werle, et al.
Pageof 86

Showing results (831-840 of 855) with videos related to

Sort By:
Pageof 86
Military Medicine|April 6, 2016
Economic Burden of Hearing Loss for the U.S. Military: A Proposed Framework for EstimationHasanat Alamgir, David L Tucker, Sun-Young Kim, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Military Medicine|December 4, 2014
The Department of Defense Epidemiologic and Economic Burden of Hearing Loss studySharon P Cooper, Hasanat Alamgir, Kristina W Whitworth, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996T B Shows, M Alders, S Bennett, et al.
Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonistsDonald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Novel Orthopoxvirus Infection in an Alaska ResidentYuri P Springer, Christopher H Hsu, Zachary R Werle, et al.
Pageof 86